Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.59 |
| ▸ | NPC1 | O15118 | 9/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1104857 | 0.83 | KDM4E (0.58) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL8112774 | 0.80 | KDM4E (0.55) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL20921174 | 0.80 | KDM4E (0.50) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL297992 | 0.80 | KDM4E (0.60) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL8052547 | 0.80 | RAB9A (0.59) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL958660 | 0.80 | RAB9A (0.58) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL14311763 | 0.80 | KDM4E (0.54) | RAB9ANPC1KDM4EMAPTHSD17B10 | |
| SCHEMBL2515278 | 0.80 | KDM4E (0.55) | RAB9ANPC1KDM4EALDH1A1LMNA | |
| SCHEMBL11823 | 0.80 | TLR8 (0.58) | RAB9ANPC1KDM4EALDH1A1MAPT | |
| SCHEMBL435075 | 0.80 | NPC1 (0.61) | RAB9ANPC1KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0318294-B1 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS (JP) | 1994-12-28 | — | — | EP | claimed |
| US-20230234937-A1 | INDENOAZANAPHTHALENES | MERCK PATENT GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
| US-20230234943-A1 | TREX1 INHIBITORS AND USES THEREOF | TEMPEST THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11702409-B2 | Pyrazolyl derivatives useful as anti-cancer agents | NOVARTIS AG (CH) | 2023-07-18 | — | — | US | disclosed |
| US-11696499-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11678498-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| EP-3381896-B1 | BIPHENYL COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO LTD (JP) | 2023-01-18 | — | — | EP | disclosed |
| US-20220407018-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2022-12-22 | — | — | US | disclosed |
| WO-2022241956-A1 | FLEXIBLE SUBSTRATE AND MANUFACTURING METHOD THEREFOR, AND DISPLAY PANEL | 深圳市华星光电半导体显示技术有限公司 | 2022-11-24 | — | — | WO | disclosed |
| US-11189809-B2 | Organic EL device and display unit | SONY CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| WO-2008117175-A2 | NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE | ADDEX PHARMA SA (CH) | 2008-10-02 | — | — | WO | disclosed |
| US-20080233387-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE | SONY CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20080233387-A1 | ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE | SONY CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20080114040-A1 | Epothilone Derivatives | NOVARTIS AG (CH) | 2008-05-15 | — | — | US | disclosed |
| US-20080114040-A1 | Epothilone Derivatives | NOVARTIS AG (CH) | 2008-05-15 | — | — | US | disclosed |
| WO-2007109334-A2 | SIP RECEPTOR MODULATING COMPOUNDS AND USE THEREOF | EPIX DELAWARE, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| EP-1539768-B1 | A NEW PROCESS FOR THE PREPARATION OF EPOTHILONE DERIVATIVES | NOVARTIS AG (CH) | 2007-09-19 | — | — | EP | disclosed |
| EP-0318294-B1 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS (JP) | 1994-12-28 | — | — | EP | disclosed |
| US-5125930-A | Polymeric cationic dyes including a quaternized pyridinium group | NIPPON CHEMICAL WORKS CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| EP-0318294-A2 | Dimeric and trimeric cationic dyes | NIPPON CHEMICAL WORKS CO., LTD (JP) | 1989-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234943-A1 | TREX1 INHIBITORS AND USES THEREOF | FEN1, ERCC4, DCLRE1B | RAB9A 2016/4885NPC1 352/4885KDM4E 2430/4885 |
| US-11702409-B2 | Pyrazolyl derivatives useful as anti-cancer agents | PAK5, CYP51A1, SF3B5 | RAB9A 607/4885NPC1 718/4885KDM4E 2184/4885 |
| US-20080114040-A1 | Epothilone Derivatives | EPOR, CYP11B2, VKORC1L1 | RAB9A 2885/4885NPC1 657/4885KDM4E 3909/4885 |
| US-20220407018-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | PPOX, EPCAM, STOM | RAB9A 1837/4885NPC1 4113/4885KDM4E 2892/4885 |
| US-20230234937-A1 | INDENOAZANAPHTHALENES | NQO1, CYP2D6, SQOR | RAB9A 3684/4885NPC1 2454/4885KDM4E 1585/4885 |
| US-11189809-B2 | Organic EL device and display unit | L1CAM, ESR1, EPHA8 | RAB9A 3991/4885NPC1 1855/4885KDM4E 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.